Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Cancer Res. 2020 Apr 3;80(9):1893–1901. doi: 10.1158/0008-5472.CAN-19-3659

Table 2.

Association between ER/PR/HER2 defined groups and Indigenous American genetic ancestry (for every 10% increase)

Covariates Subtype N OR 95% CI P-value
By HER2 status
Univariate HER2− 837 Ref.
HER2+ 392 1.10 1.02–1.19 0.012
Age dx + Afr + Height HER2− 688 Ref.
HER2+ 335 1.19 1.06–1.33 0.002
Age dx + Afr + Height + rs140068132 HER2− 688 Ref.
HER2+ 335 1.20 1.07–1.35 0.001
By ER/PR/HER2 status
Univariate ER/PR+ HER2− 638 Ref.
ER/PR- HER2+ 156 1.22 1.08–1.37 0.001
ER/PR+ HER2+ 239 1.06 0.97–1.16 0.175
ER/PR/HER2− 200 1.07 0.97–1.18 0.165
Age dx + Afr + Height ER/PR+ HER2− 531 Ref.
ER/PR- HER2+ 129 1.30 1.08–1.55 0.004
ER/PR+ HER2+ 209 1.17 1.02–1.33 0.024
ER/PR/HER2− 158 1.10 0.95–1.27 0.196
Age dx + Afr + Height + rs140068132 ER/PR+ HER2− 531 Ref.
ER/PR- HER2+ 129 1.32 1.10–1.57 0.002
ER/PR+ HER2+ 209 1.18 1.03–1.35 0.014
ER/PR/HER2− 158 1.11 0.96–1.29 0.141

Age dx: age at diagnosis; Afr: African genetic ancestry proportion